share_log

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $7

HC Wainwright & Co.维持对Gritstone Bio的买入,将目标价下调至7美元
Benzinga Real-time News ·  2022/11/07 06:22

HC Wainwright & Co. analyst Sean Lee maintains Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target from $12 to $7.

HC Wainwright & Co. 分析师肖恩·李维持Gritstone Bio(纳斯达克股票代码:GRTS)的买入并将目标股价从12美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发